Guerbet Group Overview

  • Year Founded
  • 1926

Year Founded

  • Status
  • Public

  • Employees
  • 2,746

Employees

  • Stock Symbol
  • GBT

Stock Symbol

  • Investments
  • 7

  • Share Price
  • $7.22
  • (As of Thursday Closing)

Guerbet Group General Information

Description

Guerbet SA is a healthcare company that manufactures and markets medical imaging contrast agents destined for diagnostic purposes. Its products include medical imaging contrast products for x-ray imaging, magnetic resonance imaging, ultrasound imaging and for nuclear medicine. The company markets its products under the brand names such as Xenetix, Optiray, Oxilan, Telebrix, Lipiodol, Dotarem, Endorem, Artirem, Lumirem, and Lipiodol.

Contact Information

Website
www.guerbet.com
Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • 15 rue des Vanesses
  • Zone Paris Nord II
  • 93420 Villepinte
  • France
+33 01
Primary Industry
Diagnostic Equipment
Stock Exchange
PAR
Vertical(s)
Corporate Office
  • 15 rue des Vanesses
  • Zone Paris Nord II
  • 93420 Villepinte
  • France
+33 01

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Guerbet Group Stock Performance

As of 19-Nov-2026, Guerbet Group’s stock price is $7.22. Its current market cap is $90.8M with 12.6M shares.

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$7.22 $7.24 $6.51 - $21.12 $90.8M 12.6M 11.2K -$13.37

Guerbet Group Financials Summary

As of 30-Jun-2026, Guerbet Group has a trailing 12-month revenue of $923M.

In Thousands,
USD
TTM 30-Jun-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 461,383 557,177 671,060 568,072
Revenue 923,155 900,905 920,991 860,958
EBITDA 48,154 (33,031) 109,159 110,874
Net Income (163,962) (122,198) 17,404 25,825
Total Assets 1,113,112 1,092,414 1,079,337 1,133,302
Total Debt 548,440 518,266 411,155 427,522
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Guerbet Group Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Guerbet Group‘s full profile, request access.

Request a free trial

Guerbet Group Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Guerbet SA is a healthcare company that manufactures and markets medical imaging contrast agents destined for diagnostic
Diagnostic Equipment
Villepinte, France
2,746 As of 2025

Chicago, IL
 

Bedford, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Guerbet Group Competitors (5)

One of Guerbet Group’s 5 competitors is GE HealthCare Technologies, a Corporation company based in Chicago, IL.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
GE HealthCare Technologies Corporation Chicago, IL
Lantheus Holdings Formerly PE-Backed Bedford, MA
NeuroLogica Formerly VC-backed Danvers, MA
FluoroPharma Formerly VC-backed Montclair, NJ
Analogic Private Equity-Backed Salem, NH
You’re viewing 5 of 5 competitors. Get the full list »

Guerbet Group Patents

Guerbet Group Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026215310-A1 Disubstituted macrocyclic ligands, complexes thereof and medical uses thereof Pending 08-Apr-2025
WO-2026215340-A1 Method for regioselective prepration of di- or tri-substituted macrocyclic ligands Pending 08-Apr-2025
EP-4814865-A1 A computer-implemented method for estimating the body composition of a patient from a restricted-field-of-view medical image Pending 27-Mar-2025
WO-2026202140-A1 A computer-implemented method for estimating the body composition of a patient from a restricted-field-of-view medical image Pending 27-Mar-2025
EP-4811287-A1 A computer-implemented method for pairing anatomical entities of at least one patient on medical images Pending 21-Mar-2025 G06T7/30
To view Guerbet Group’s complete patent history, request access »

Guerbet Group Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Guerbet Group Investments & Acquisitions (7)

Guerbet Group’s most recent deal was a Merger/Acquisition with Intrasense. The deal was made on 05-Jun-2023.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Intrasense 05-Jun-2023 Merger/Acquisition Decision/Risk Analysis
Intrasense 11-Jan-2023 PIPE Decision/Risk Analysis
Accurate Medical Therapeutics 02-Aug-2018 Merger/Acquisition Surgical Devices
Occlugel (laboratory-stage technology) 26-Apr-2018 Corporate Asset Purchase Buildings and Property
Mallinckrodt (CMDS Business) 27-Nov-2015 Merger/Acquisition Diagnostic Equipment
You’re viewing 5 of 7 investments and acquisitions. Get the full list »

Guerbet Group ESG

Risk Overview

Risk Rating

Updated November, 04, 2026

19.67 | Low Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 13,593

Rank

Percentile

Healthcare

Industry

of 590

Rank

Percentile

Medical Supplies

Subindustry

of 60

Rank

Percentile

To view Guerbet Group’s complete esg history, request access »

Guerbet Group Affiliates

Subsidiaries (6)

Name Industry Location Year Founded
Guerbet France Villepinte, France 2012
Guerbet Milan, Italy 2011
Intrasense Montpellier, France 2004
Guerbet Laboratories Solihull, United Kingdom 1994
Medex Biomedical Saint Priest, France 1988
You’re viewing 5 of 6 affiliates. Get the full list.  »

Guerbet Group FAQs

  • When was Guerbet Group founded?

    Guerbet Group was founded in 1926.

  • Where is Guerbet Group headquartered?

    Guerbet Group is headquartered in Villepinte, France.

  • What is the size of Guerbet Group?

    Guerbet Group has 2,746 total employees.

  • What industry is Guerbet Group in?

    Guerbet Group’s primary industry is Diagnostic Equipment.

  • Is Guerbet Group a private or public company?

    Guerbet Group is a Public company.

  • What is Guerbet Group’s stock symbol?

    The ticker symbol for Guerbet Group is GBT.

  • What is the current stock price of Guerbet Group?

    As of 19-Nov-2026 the stock price of Guerbet Group is $7.22.

  • What is the current market cap of Guerbet Group?

    The current market capitalization of Guerbet Group is $90.8M.

  • What is Guerbet Group’s current revenue?

    The trailing twelve month revenue for Guerbet Group is $923M.

  • Who are Guerbet Group’s competitors?

    GE HealthCare Technologies, Lantheus Holdings, NeuroLogica, FluoroPharma, and Analogic are competitors of Guerbet Group.

  • What is Guerbet Group’s annual earnings per share (EPS)?

    Guerbet Group’s EPS for 12 months was -$13.37.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process